Distributor and Placement Agent Due Diligence for Fund Managers
Many funds reach investors through distributors, placement agents, platforms and nominees. Each intermediary changes who your customer is, what you must check and what you can rely on. This paper sets out a staged framework for classifying and assessing intermediaries, writing the anti-money laundering and counter-terrorist financing (AML/CFT) terms of the distribution agreement and overseeing the network.
This paper is for chief compliance officers, money laundering reporting officers (MLROs), heads of distribution and chief operating officers at fund managers, and for the fund administrators and transfer agents that support them. "Placement agent" is used here as an umbrella term: the regulations speak of distributors, intermediaries, introducers and nominees.
It covers the distributor itself as a counterparty. For the general rules on reliance and omnibus investors, see our glossary entries on third-party reliance and the omnibus account, and our guide to KYC for fund of funds and nominee investors.
The paper cites rules of the Monetary Authority of Singapore (MAS), Hong Kong's Securities and Futures Commission (SFC), Luxembourg's Commission de Surveillance du Secteur Financier (CSSF) and the Cayman Islands Monetary Authority (CIMA). It also cites the UK Money Laundering Regulations 2017 (MLR), the Cayman Anti-Money Laundering Regulations (AMLRs) and the EU Anti-Money Laundering Regulation (AMLR).
Four Roles a Distributor Can Play
The same firm can play different roles for different funds, or for different investors in one fund, so classify each relationship first. Under the EBA Guidelines, the CDD measures a fund should take depend on how the investor comes to it; one way to establish this is to ask applicants to declare whether they invest for themselves or as an intermediary for someone else (Guideline 16.13).
| What the distributor does | Who your customer is | What you owe | Examples of the basis |
|---|---|---|---|
| A. Introduces only. Refers or prospects investors, who then subscribe in their own name | The investor | Full CDD on the investor; due diligence on the distributor as a business partner, not as a customer | MAS Guidelines 2-4 (no CDD where the firm solely prospects, without the provision of financial advice); CIMA Guidance Notes Part II s4.B paras 6-7 |
| B. Introduces and performs CDD you rely on. The distributor has done the checks | The investor | Reliance conditions, a written basis for reliance, access to CDD on request, periodic testing. Ongoing monitoring stays with you | MAS Notice 9.2-9.5; SFC 4.15; UK MLR reg 39; Cayman AMLRs reg 25; AMLR Arts 48-49 from 10 July 2027 |
| C. Invests in its own name for its clients. Nominee, platform or omnibus holder on your register | The intermediary (with risk-based measures on underlying investors) | CDD on the intermediary, plus enhanced, correspondent-style due diligence where the regime requires it | CSSF Regulation 12-02 Art 3; SFC 4.20 and footnote 66; EBA Guidelines 16.14 to 16.20; Cayman AMLRs reg 24 |
| D. Acts as your delegate. Performs onboarding under your procedures and control | The investor | Outsourcing controls: selection, written agreement, access, regular control. You remain fully liable | MAS Guidelines 9-1 to 9-3; SFC 4.15.2; UK MLR reg 39(7)-(8); CSSF 12-02 Art 37; AMLR Art 18 |
Two distinctions matter most. First, under reliance, the third party applies its own procedures to a customer relationship of its own; under outsourcing, the provider follows your procedures under your control (MAS Guidelines 9-1 to 9-3; CIMA Guidance Notes Part II s2.C paras 9-11). Second, an intermediary that invests in its own name is your applicant for business, while an introducer is not (CIMA Part II s4.B paras 6-7). The regime also matters: under the MAS Guidelines, the end investors in funds marketed by a distributor are treated as beneficial owners of the customer of the manager, which is the fund (Guidelines 2-3(b)).
Responsibility does not move in any of the four models. MAS Notice SFA04-N02 says the manager "shall remain responsible" despite reliance (para 9.5); the SFC, the UK, the Cayman Islands and the AMLR say the same in their own terms (SFC 4.15.1; MLR reg 39(1) and, for agents and outsourcing, reg 39(7); AMLRs regs 3(3) and 25(3); AMLR Arts 18(2) and 48(1)).
When a Distributor Relationship Is Treated Like Correspondent Banking
Where an intermediary invests for its own clients, particularly from another country, several regimes apply correspondent banking standards, which focus on the intermediary's own AML/CFT framework rather than on each underlying investor.
| Regime | When a distributor relationship gets correspondent-style treatment | What that adds |
|---|---|---|
| Hong Kong (SFC) | The cross-border correspondent rules in section 4.20 apply to a licensed corporation dealing in fund units for a customer that is a distributor outside Hong Kong for funds under its management (footnote 66) | CDD on the distributor, plus understanding its business, reputation and supervision, assessing its AML/CFT controls, senior management approval and a clear understanding of the respective AML/CFT responsibilities (4.20.5). No duty under 4.20 to perform CDD on the distributor's own customers (footnote 70) |
| Luxembourg (CSSF) | Where units are subscribed through an intermediary acting for others, the relationship is "similar to correspondent relationship" (Regulation 12-02 Art 3(2)); similar relationships include those for securities transactions (Art 29) | Enhanced due diligence on the intermediary aimed at the robustness of its AML/CFT framework; information on its country, supervisor and ownership; a documented decision; periodic review; checks that it keeps its commitments, notably to communicate client identification data without delay on request (Art 28, applied to marketing intermediaries by Circular 18/698 point 329) |
| European Union (EBA) | A financial intermediary in a third country that has a relationship similar to correspondent banking with the fund or its manager (Guideline 16.17) | The measures in Guidelines 16.20 and 16.21 (risk-sensitive CDD on the intermediary with possible simplified due diligence, or reliance on the intermediary) do not apply; firms should apply the correspondent enhanced due diligence measures in Guidelines 8.14 to 8.17 instead |
| Singapore (MAS) | Paragraph 10 applies where the manager provides correspondent account services in Singapore to a financial institution outside Singapore: cross-border services in any activity regulated under the Securities and Futures Act, for that institution or its customers (Notice 10.1 and 10.2). MAS does not expressly apply it to distributors; for distributors, the Guidelines instead expect a confirmation that the distributor is responsible for AML/CFT checks on the underlying investors (Guidelines 2-3(b)) | Assess the respondent, document respective AML/CFT responsibilities and obtain senior management approval (10.3); no relationship with an institution lacking adequate controls or effective supervision, or a shell (10.6) |
| United Kingdom and EU AMLR | Correspondent rules in MLR 2017 reg 34 and AMLR Art 36 (from 10 July 2027) cover third-country relationships "involving the execution of payments", including securities relationships | Applies to a distribution relationship only where that qualifier is met; check each arrangement |
In the EU, the Anti-Money Laundering Authority (AMLA) announced on 1 October 2026 that it had submitted final draft regulatory technical standards on CDD under Article 28(1) AMLR to the European Commission. Draft Article 15 covers a collective investment undertaking that distributes through a credit or financial institution acting in its own name for final investors. Such a fund could meet the requirement in Article 20(1)(h) AMLR (identifying and verifying the natural persons on whose behalf a transaction is conducted) on four conditions: the intermediary is subject to equivalent AML/CFT obligations, it is effectively supervised, the risk of the relationship is not high, and the fund is satisfied that it applies robust CDD to its own customers. AMLA removed an earlier requirement for the intermediary to provide final-investor information, to prevent a reading that funds must systematically look through to underlying investors.
The draft is not yet adopted. For how this affects investor files, see our guide to AIFM AML and investor KYC in the EU.
Stage 1: Map the Distribution Network
Build a register of every party between the fund and its investors: distributors, placement agents, platforms, nominees and their sub-distributors. For each, record the funds and share classes it distributes, its countries of activity, the role it plays (A to D above) and whether it holds units in its own name. In Luxembourg, an investment fund manager must submit annually to the CSSF a list of all marketing intermediaries with which it is in a direct relationship, within five months of its financial year-end (Circular CSSF 18/698, point 325).
Stage 2: Risk-Assess Each Distributor
Assess each intermediary before the agreement is signed. The CSSF requires initial and ongoing due diligence on marketing intermediaries, including collecting "Know Your Intermediary" documents. Its minimum content covers the intermediary's type, country, AML/CFT regime and supervisor, ownership, reputation and the quality of its supervision, together with the risk of the distribution channel and of the country (Circular 18/698, point 328). MAS suggests sources for assessing a relied-upon third party that also suit this assessment, such as mutual evaluation reports, public reports on the third party's compliance and a review of its policies and procedures (Guidelines 9-4).
| Factor | Lower risk indicators | Higher risk indicators (red flags) |
|---|---|---|
| Regulatory status | Authorised for AML/CFT in a jurisdiction with requirements at least as robust as yours, and effectively supervised (EBA 16.11 and 16.20) | Unregulated, or regulated only for conduct; uses intermediaries not subject to adequate AML/CFT laws (MAS Guidelines, Appendix B) |
| Jurisdiction | Country risk understood and documented (MAS Notice 9.2(b); CIMA Guidance Notes Part II s2.C para 12) | Located in a jurisdiction associated with higher ML/TF risk (CSSF Circular 18/698 point 328; EBA 16.10) |
| Channel structure | Units bought and redeemed only through firms subject to robust AML/CFT requirements (EBA 16.11) | Complex channels or a large number of sub-distributors, particularly in third countries (EBA 16.10); non-regulated nominee companies in several jurisdictions (EBA 16.8) |
| Information access | Contract and testing show CDD records arrive on request | Reluctance or delay in producing CDD on request (CIMA Guidance Notes Part II s5.E para 10); resistance to audit or testing rights, or to clauses on retention and hand-over of records |
| Client base and product | Client base and target markets match the fund's distribution plan | Clients or markets outside the agreed plan; third-party subscribers or payees, especially where unexpected (EBA 16.6; CIMA Part VI s1.I para 1) |
| History | Stable relationship; clean results from sample testing | Adverse media or regulatory action; a pattern of failed tests; frequent or unexplained changes of service providers (by analogy with CIMA Part VI s1.D para 4(1), a risk factor CIMA lists for funds) |
The table is our illustration: weight the factors in line with your enterprise-wide risk assessment and record the reasons for each rating. In Luxembourg, unclear or complex channels and a location in a higher-risk jurisdiction call for enhanced monitoring (point 328).
Stage 3: Build the Due Diligence File
A distributor file should let a reviewer see who the intermediary is, why it was accepted and on what terms. We recommend keeping at least:
- Identification of the intermediary, its representatives and its beneficial owners (CSSF 12-02 Art 3(2)).
- Evidence of its authorisation, regulator and AML/CFT supervision.
- Its AML/CFT policies and procedures, or a reviewed summary, and the outcome of your review.
- The country risk assessment for each jurisdiction where it operates (MAS Notice 9.2(b)).
- Screening results for the entity and its key individuals, and any adverse media review.
- The risk rating, its rationale and the approval record.
- The signed distribution agreement and any side letters dealing with AML/CFT.
- Where you rely on it for CDD, the documented basis for being satisfied that it meets the reliance conditions (MAS Notice 9.4(a); SFC 4.15.3).
Stage 4: Write the AML/CFT Terms of the Distribution Agreement
Investor-level AML confirmation letters do not replace the agreement with the distributor. In Luxembourg, where the manager deals directly with marketing intermediaries, the respective AML/CFT responsibilities must be set out in a written contract (Circular 18/698, point 324). From 10 July 2027, reliance under the AMLR also requires a written agreement (Art 49(4)). The table sets out clauses we recommend, with the provisions that support them.
| Clause | What it should say | Regulatory anchor |
|---|---|---|
| Allocation of AML/CFT duties | Which party performs which CDD measures, screening, record-keeping and suspicious transaction reporting, and for which investors | CSSF 18/698 point 324 (written contract required); MAS Notice 10.3(b); SFC 4.20.5(e) |
| Confirmation of responsibility | Where investors are the distributor's clients, its confirmation that it is responsible for AML/CFT checks on them | MAS Guidelines 2-3(b); SFC 4.15.3(a) (where you rely on it, written confirmation that it agrees to act as your intermediary and which CDD measures it performs) |
| Access to CDD records | Copies of identification, verification and other CDD records on request, with a stated deadline | UK reg 39(2)(b) ("immediately on request"); MAS Notice 9.2(d) ("without delay"); EBA 16.20 ("immediately upon request"); AMLR Art 49(3) ("in any case within 5 working days") from 10 July 2027 |
| Retention and hand-over | Retention for at least the required period, and transfer of all CDD records if the distributor ceases trading or the agreement ends | MAS Guidelines 9-5 (at least five years); SFC 4.15.5; CIMA Part II s5.E para 19 |
| Testing and audit rights | Your right to sample-test CDD files and review the distributor's AML/CFT policies | SFC 4.15.6; CIMA Part II s5.E para 18; EBA 16.20 (contract or sample testing) |
| Notification | Prompt notice of regulatory action, a material control failure, a change of control, or inability to meet the agreement | CIMA Part II s5.E para 19 (notice if no longer able to comply) |
| Sub-distribution and new markets | No appointment of sub-distributors and no marketing in new countries without your prior consent | CSSF 18/698 point 330(a) (involvement in decisions on new countries of registration); EBA 16.10 |
| Termination | Your right to suspend or end the relationship for AML/CFT failures, with continued access to records | CIMA Part II s5.E para 17 (consider discontinuing on a pattern of non-compliance); SFC 4.15.7 |
Where an administrator or transfer agent holds the register, we recommend that its own agreement with the fund gives the manager the information it needs to oversee distributors. In Luxembourg, a manager that has delegated the registrar agent function must, by contract, oblige the registrar agent to make available the information the manager needs to meet its AML/CFT obligations. The contract must also set out their respective AML/CFT responsibilities, including for due diligence on marketing intermediaries (CSSF Circular 18/698, points 334 to 337).
Stage 5: Approve and Onboard
Where a relationship falls within the correspondent rules, Singapore requires senior management approval before correspondent account services are provided to a new financial institution (MAS Notice 10.3(c)). The SFC expects the same approval before a cross-border correspondent relationship is established (SFC 4.20.5(d) and 4.20.10). In the Cayman Islands, only senior management should decide that reliance may be placed on an eligible introducer, with the basis recorded (CIMA Part II s5.E para 9). We recommend the same approval route for every higher-risk distributor.
Do not start accepting subscriptions through a new intermediary until the file is complete, the agreement is signed and the administrator has the distributor code needed to report dealing by channel.
Stage 6: Oversee the Network Over Time
CIMA describes the reliance decision as one that "is not static" and should be assessed regularly (Part II s5.E para 12). The CSSF requires periodic, risk-based assessments to confirm that each intermediary keeps its commitments, and re-examination when adverse information emerges (Circular 18/698, point 329).
- 1. Periodic review. Refresh each distributor's file on a cycle set by its risk rating, and on trigger events such as regulatory action, a change of control or expansion into new markets.
- 2. Sample testing. Request CDD files for a sample of investors introduced or held by the distributor and check them against the agreement. The SFC expects tests "from time to time" (4.15.6). CIMA says firms must keep a record of the testing, including any delays and remediation (Part II s5.E para 18).
- 3. Monitoring. Keep ongoing monitoring of business relations in-house: MAS does not allow reliance on a third party for it (Notice 9.3), and the SFC says the same (footnote 57). Review dealing data by distributor for unusual patterns.
- 4. Market changes. Be involved in decisions on new countries of registration and keep contracts up to date (Circular 18/698, point 330).
- 5. Escalation and exit. Where an intermediary shows a pattern of non-compliance, consider whether to end the relationship; CIMA says this where an eligible introducer fails or is unable to provide the required written confirmation (Part II s5.E para 17). If you end it, obtain all CDD information immediately (SFC 4.15.7).
United States: The Investment Adviser Rule
The anti-money laundering rule for investment advisers issued by the Financial Crimes Enforcement Network (FinCEN) now takes effect on 1 January 2028 (91 FR 36). In its 2024 final rule, FinCEN said advisers may delegate the implementation and operation of their programme by contract, but remain fully responsible and legally liable for it. A certification from a service provider that it has a satisfactory AML programme would not be enough on its own (89 FR 72188).
FinCEN declined to let advisers expressly rely on diligence by other institutions or intermediaries (89 FR 72189). Where a fund or its investors present higher risk, an adviser may need more information on underlying investors (89 FR 72195-72196). See our guide to the FinCEN investment adviser AML rule.
Roles and Governance
| Role | Responsibility |
|---|---|
| Board or senior management | Approves the distribution policy and risk appetite for intermediaries, each correspondent-style relationship, each reliance on an eligible introducer and, on our recommendation, other higher-risk distributors (Stage 5) |
| Distribution or investor relations lead | Proposes distributors, provides the business case and target markets, and owns the commercial relationship |
| Compliance officer or MLRO | Runs know-your-intermediary due diligence, sets the risk rating, reviews testing results and escalates failures |
| Legal | Drafts and maintains the AML/CFT clauses in distribution agreements |
| Administrator or transfer agent | Supplies register and dealing data by distributor, flags exceptions and supports sample testing under its own agreement with the fund |
Common Failure Points
- One template for every intermediary, so the file does not show which rules apply.
- No AML/CFT terms in the agreement: no allocation of duties, no deadline for records, no testing rights.
- Reliance without testing: confirmations collected at onboarding and never checked.
- Invisible sub-distributors behind the main distributor.
- No exit plan, so CDD records stay with a former distributor.
Distributor Due Diligence Checklist
- Every intermediary listed, with its role (A to D) recorded.
- Correspondent-style rules checked for each cross-border intermediary.
- Due diligence and risk rating completed before signing.
- Stage 4 clauses in every distribution agreement.
- Senior management approval for higher-risk and correspondent-style relationships.
- Dealing and register data by distributor available from the administrator.
- Testing and reviews scheduled by risk rating and recorded.
- Escalation, restriction and exit decisions recorded.
- Ongoing monitoring retained in-house.
- Regime-specific deadlines diarised, such as the annual CSSF list of marketing intermediaries.
How One Constellation Supports This
One Constellation is a software-as-a-service (SaaS) AML and know-your-customer (KYC) compliance platform headquartered in Singapore. It provides know-your-business (KYB) and beneficial ownership checks, sanctions, politically exposed person (PEP) and adverse-media screening, investor onboarding and case management, so that intermediary due diligence, testing results and decisions sit in one record.
This paper is general information, not legal advice. Check the current text of each rule with the regulator before relying on it.
Sources
Sources: MAS Notice SFA04-N02 (30 June 2025) · Guidelines to MAS Notice SFA04-N02 · SFC AML/CFT Guideline (June 2023) · UK MLR 2017, reg 39 · UK MLR 2017, reg 34 · EBA ML/TF Risk Factors Guidelines (EBA/GL/2021/02), Guideline 16 · Regulation (EU) 2024/1624 (AMLR) · AMLA: final draft standards submitted to the Commission · CSSF Regulation No 12-02 · Circular CSSF 18/698 · Cayman Anti-Money Laundering Regulations (2025 Revision) · CIMA Guidance Notes (February 2024) · FinCEN investment adviser AML rule, 89 FR 72156 · FinCEN delay to 1 January 2028, 91 FR 36. Read on 20 November 2026.
Keep Intermediary Due Diligence in One Record
KYB and beneficial ownership checks, screening, investor onboarding and case management for fund managers, administrators and transfer agents.
